1Weidner N, Folkman J, Pozza F, et al. Tumor angiogenesis: a new significent and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst, 1992, 84:1875-1887.
2Augustin HG. Angiogenic tumor therapy: will it work? Trends Pharmacol Sci, 1998, 19:216-222.
3Gospodarowicz D, Ferrara N, Schweigerer L, et al. Structural characterization and biological functions of fibroblast growth factor.Endocr Rev,1987, 8:95-114.
4Van der Zee R, Murohara T, Lao Z, et al. Vascular endothelial growth factor/vascular permeability factor augments nitric oxide release from quiescent rabbit and human vascular endothelium. Circulation, 1997,95 : 1030-1037.
5Toi M, Hoshina S, Takayanagi T, et al. Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer. Jpn J Cancer Res, 1994, 85:1045-1049.
6Bosari S, Lee AK, DeLellis RA, et al. Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol, 1992,23:755-761.
7Van Hoef ME, Knox WF, Dhesi SS, et al. Assessment of tumour vascularity as a prognostic fator in lymph node negative invasive breast cancer. Eur J Cancer, 1993,29A:1141-1145.
8Medri L, Nanni O, Volpi A, et al. Tumor microvessel density and prognosis in node-negative breast cancer. Int J Cancer, 2000,89:74-80.
9Brown LF,Berse B,Jackman RW,et al.Expression of vascular permeability factor (vascular endothelial growth fractor) and its receptors in breast cancer[].Human Pathology.1995
10Boocock CA,Charnock-Jones DS,Sharkey AM,et al.Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma[].Journal of the National Cancer Institute.1995
1Kaya A, Ciledag A, Gulbay BE, et al. The prognostic significance of vascular endothelial growth factor levels in sera of non - small cell lung cancer patients. Bespir Med, 2004, 98(7) :632 -663.
2Kishiro I, Kato S, Fuse D,et al. Clinical significance of vascular endothelial growth factor in patients with primary lung cancer. Bespirology,2002,7(2) : 93 -98.
3Rioux N, Castonguay A. Prevention of NNK - induced lung tumorigenesis in A/J mice by acetylsalicylic acid and NS - 398. Cancer Res,1998,58 (23) :5354 -5360.
4Kanda A, Ebihara S, Takahashi H, et al. Loxoprofen sodium suppresses mouse tumor growth by inhibiting vascular endothelial growth factor. Acta Oncol,2003,42 ( 1 ) :62 - 70.
5Shibuya M. Structure and function of VEGF/VEGF - receptor system involving in angiogenesis. Cell Struct Funct,2001,26 (1) :25 -35.
6Kim HS, Youm HR, Lee JS, et al. Correlation between cyclooxygenase- 2 and tumor angiogenesis in non - small lung cancer. Lung Cancer, 2003, 42(2) :163 - 170.
7Akhmedkhanov A, Toniolo P, Zeleniuch - Jacquotte A, et al. Aspirin and lung cancer in women. Br J Cancer,2002,87 ( 1 ) : 49 - 53.
